blinatumomab
amgen
['bet', 'blina ', 'leusm', 'blinatumomab', 'leukemia', '2018', 'lymphoma']
#ash22 #leusm boissel: blin during consolidation (start wk12) in high risk b-all (kmt2ar or ikzf1del or mrd&gt;10e-4) graal2014/b quest substudy. internal control cohort of 104 pts before addition of quest (blin) substudy. bridge to allo in mrd &gt;10e-3 at eoi or &gt;10e-4 at wk12. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)